Terms: = Head and neck cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Treatment
30 results:
1. Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary cancer.
Chinchilla-Tábora LM; Montero JC; Corchete LA; González-Morais I; Del Barco Morillo E; Olivares-Hernández A; Rodríguez González M; Sayagués JM; Ludeña MD
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396726
[TBL] [Abstract] [Full Text] [Related]
2. Germline genetic biomarkers to stratify patients for personalized radiation treatment.
Deichaite I; Hopper A; Krockenberger L; Sears TJ; Sutton L; Ray X; Sharabi A; Navon A; Sanghvi P; Carter H; Moiseenko V
J Transl Med; 2022 Aug; 20(1):360. PubMed ID: 35962345
[TBL] [Abstract] [Full Text] [Related]
3. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
4. Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients.
Daiko H; Marafioti T; Fujiwara T; Shirakawa Y; Nakatsura T; Kato K; Puccio I; Hikichi T; Yoshimura S; Nakagawa T; Furukawa M; Stoeber K; Nagira M; Ide N; Kojima T
Cancer Immunol Immunother; 2020 Nov; 69(11):2247-2257. PubMed ID: 32500232
[TBL] [Abstract] [Full Text] [Related]
5. Is nasopharyngeal carcinoma in young patients a distinct clinical entity? A single-institution case matched analysis in the era of intensity-modulated radiotherapy.
Ou D; Wang X; Xue F; Niu X; Liu P; Hu C; He X
Oral Oncol; 2020 Aug; 107():104779. PubMed ID: 32413726
[TBL] [Abstract] [Full Text] [Related]
6. HLA Class I Expression Changes in Different Types of Cultured Parathyroid Cells.
Goncu B; Yucesan E; Aysan E; Kandas NO
Exp Clin Transplant; 2022 Sep; 20(9):854-862. PubMed ID: 30995898
[TBL] [Abstract] [Full Text] [Related]
7. Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood.
Fan PW; Huang L; Chang XM; Feng YN; Yao X; Peng YC; Dong T; Wang RZ
Chin Med J (Engl); 2018 Jun; 131(11):1289-1295. PubMed ID: 29786040
[TBL] [Abstract] [Full Text] [Related]
8. Somatic Host Cell Alterations in HPV Carcinogenesis.
Litwin TR; Clarke MA; Dean M; Wentzensen N
Viruses; 2017 Aug; 9(8):. PubMed ID: 28771191
[TBL] [Abstract] [Full Text] [Related]
9. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.
Wichmann G; Herchenhahn C; Boehm A; Mozet C; Hofer M; Fischer M; Kolb M; Dietz A
Oral Oncol; 2017 Jun; 69():115-127. PubMed ID: 28559015
[TBL] [Abstract] [Full Text] [Related]
10. Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the head and neck.
Saloura V; Fatima A; Zewde M; Kiyotani K; Brisson R; Park JH; Ikeda Y; Vougiouklakis T; Bao R; Khattri A; Seiwert T; Cipriani N; Lingen M; Vokes E; Nakamura Y
Clin Cancer Res; 2017 Aug; 23(16):4897-4907. PubMed ID: 28442504
[No Abstract] [Full Text] [Related]
11. Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal cancer.
Kannan A; Hertweck KL; Philley JV; Wells RB; Dasgupta S
Sci Rep; 2017 Apr; 7():46102. PubMed ID: 28383029
[TBL] [Abstract] [Full Text] [Related]
12. Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.
Da Silva DM; Woodham AW; Naylor PH; Egan JE; Berinstein NL; Kast WM
J Interferon Cytokine Res; 2016 May; 36(5):291-301. PubMed ID: 26653678
[TBL] [Abstract] [Full Text] [Related]
13. Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma.
Zheng Y; Parsonage G; Zhuang X; Machado LR; James CH; Salman A; Searle PF; Hui EP; Chan AT; Lee SP
Cancer Immunol Res; 2015 Oct; 3(10):1138-47. PubMed ID: 25711537
[TBL] [Abstract] [Full Text] [Related]
14. hla-a*02 in relation to outcome in human papillomavirus positive tonsillar and base of tongue cancer.
Tertipis N; Villabona L; Nordfors C; Näsman A; Ramqvist T; Vlastos A; Masucci G; Dalianis T
Anticancer Res; 2014 May; 34(5):2369-75. PubMed ID: 24778045
[TBL] [Abstract] [Full Text] [Related]
15. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
Mountzios G; Rampias T; Psyrri A
Ann Oncol; 2014 Oct; 25(10):1889-1900. PubMed ID: 24718888
[TBL] [Abstract] [Full Text] [Related]
16. Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients.
Iinuma H; Fukushima R; Inaba T; Tamura J; Inoue T; Ogawa E; Horikawa M; Ikeda Y; Matsutani N; Takeda K; Yoshida K; Tsunoda T; Ikeda T; Nakamura Y; Okinaga K
J Transl Med; 2014 Apr; 12():84. PubMed ID: 24708624
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of secondary and primary thyroid cancer in adolescents and young adults.
Goldfarb M; Freyer DR
Cancer; 2014 Apr; 120(8):1155-61. PubMed ID: 24615715
[TBL] [Abstract] [Full Text] [Related]
18. The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers.
Oji Y; Tatsumi N; Fukuda M; Nakatsuka S; Aoyagi S; Hirata E; Nanchi I; Fujiki F; Nakajima H; Yamamoto Y; Shibata S; Nakamura M; Hasegawa K; Takagi S; Fukuda I; Hoshikawa T; Murakami Y; Mori M; Inoue M; Naka T; Tomonaga T; Shimizu Y; Nakagawa M; Hasegawa J; Nezu R; Inohara H; Izumoto S; Nonomura N; Yoshimine T; Okumura M; Morii E; Maeda H; Nishida S; Hosen N; Tsuboi A; Oka Y; Sugiyama H
Int J Oncol; 2014 May; 44(5):1461-9. PubMed ID: 24589652
[TBL] [Abstract] [Full Text] [Related]
19. Percutaneous radiologic gastrostomy in patients with malignant pharyngoesophageal obstruction.
Inaba Y; Yamaura H; Sato Y; Kashima M; Kato M; Inoue D; Kurinobu T; Sato T
Jpn J Clin Oncol; 2013 Jul; 43(7):713-8. PubMed ID: 23698854
[TBL] [Abstract] [Full Text] [Related]
20. MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome.
Näsman A; Andersson E; Nordfors C; Grün N; Johansson H; Munck-Wikland E; Massucci G; Dalianis T; Ramqvist T
Int J Cancer; 2013 Jan; 132(1):72-81. PubMed ID: 22592660
[TBL] [Abstract] [Full Text] [Related]
[Next]
